• Combat Medical

  Participated · Series A · Mar 2026

  Combat Medical develops device-assisted hyperthermic therapies designed to improve the delivery and efficacy of cancer chemotherapies, notably its HIVEC intravesical system for bladder cancer. The company has an installed base of over 350 systems and reports completion of more than 100,000 HIVEC treatments to date. Combat is running the HIVEC HEAT phase 3 pivotal trial aimed at FDA registration for treatment of BCG-unresponsive non-muscle-invasive bladder cancer. It also has clinical programs targeting peritoneal cancer (HIPEC) and plans to expand those as it scales. Recent financing (a £2.6 million Series A first close) is intended to fund the phase 3 trial and preparatory activities for U.S. regulatory submissions and commercial expansion. Management has stated it will pursue future financings to complete FDA registration and grow operations.

• Alto Technologies

  Participated · Seed · Nov 2025

  Founded in 2022 in Saskatoon, Alto Technologies has built a health-tech marketplace that eliminates traditional agency overhead by linking caregivers directly with seniors, people with disabilities, and other at-home care recipients. The platform handles scheduling, payroll, and automated billing/reporting for provincial and federal funding programs, reducing customer costs while increasing caregivers’ take-home pay. Alto currently serves roughly 4,000 combined caregivers and care seekers across Saskatchewan and parts of Alberta. Initial traction came from the senior-care segment, and the company has since expanded into disability services. Management’s immediate roadmap includes adding new caregiver-centric features and broadening geographic coverage across Canada. The founders emphasize maintaining safety and security standards while scaling. No revenue figures were disclosed in the article.

No current team members are available.